Adaptimmune Therapeutics PLC (ADAP)
0.8335
+0.03
(+4.21%)
USD |
NASDAQ |
Nov 04, 13:00
Adaptimmune Therapeutics Max Drawdown (5Y): 96.45% for Oct. 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| October 31, 2024 | 96.45% |
| September 30, 2024 | 96.45% |
| August 31, 2024 | 96.57% |
| July 31, 2024 | 96.57% |
| June 30, 2024 | 96.57% |
| May 31, 2024 | 96.57% |
| April 30, 2024 | 96.57% |
| March 31, 2024 | 96.57% |
| February 29, 2024 | 96.57% |
| January 31, 2024 | 96.57% |
| December 31, 2023 | 96.57% |
| November 30, 2023 | 96.57% |
| October 31, 2023 | 96.57% |
| September 30, 2023 | 96.57% |
| August 31, 2023 | 96.57% |
| July 31, 2023 | 96.57% |
| June 30, 2023 | 96.57% |
| May 31, 2023 | 96.57% |
| April 30, 2023 | 96.57% |
| March 31, 2023 | 96.57% |
| February 28, 2023 | 96.57% |
| January 31, 2023 | 96.57% |
| December 31, 2022 | 96.57% |
| November 30, 2022 | 96.57% |
| October 31, 2022 | 96.57% |
| Date | Value |
|---|---|
| September 30, 2022 | 96.57% |
| August 31, 2022 | 96.57% |
| July 31, 2022 | 96.57% |
| June 30, 2022 | 96.57% |
| May 31, 2022 | 96.57% |
| April 30, 2022 | 96.57% |
| March 31, 2022 | 96.57% |
| February 28, 2022 | 96.57% |
| January 31, 2022 | 96.57% |
| December 31, 2021 | 96.57% |
| November 30, 2021 | 96.57% |
| October 31, 2021 | 96.57% |
| September 30, 2021 | 96.57% |
| August 31, 2021 | 96.57% |
| July 31, 2021 | 96.57% |
| June 30, 2021 | 96.57% |
| May 31, 2021 | 96.57% |
| April 30, 2021 | 96.57% |
| March 31, 2021 | 96.57% |
| February 28, 2021 | 96.57% |
| January 31, 2021 | 96.57% |
| December 31, 2020 | 96.57% |
| November 30, 2020 | 96.57% |
| October 31, 2020 | 96.57% |
| September 30, 2020 | 96.57% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
96.45%
Minimum
Sep 2024
96.57%
Maximum
Nov 2019
96.56%
Average
96.57%
Median
Nov 2019
Max Drawdown (5Y) Benchmarks
| Biodexa Pharmaceuticals PLC | 100.00% |
| Verona Pharma PLC | 89.71% |
| NuCana PLC | 99.28% |
| Autolus Therapeutics PLC | 96.58% |
| Bicycle Therapeutics PLC | 78.82% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -35.27 |
| Beta (5Y) | 2.256 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 155.8% |
| Historical Sharpe Ratio (5Y) | -0.0394 |
| Historical Sortino (5Y) | -0.156 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 36.67% |